Cargando…
Effect of Metabolic Syndrome on Risk Stratification for Left Atrial or Left Atrial Appendage Thrombus Formation in Patients with Nonvalvular Atrial Fibrillation
BACKGROUND: Metabolic syndrome (MS) is a risk factor for stroke and thromboembolism event. Left atrial or LA appendage (LA/LAA) thrombus is a surrogate of potential stroke. The relationship between MS and atrial thrombus remains unclear. In this study, we sought to investigate the effect of MS on ri...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072249/ https://www.ncbi.nlm.nih.gov/pubmed/27748329 http://dx.doi.org/10.4103/0366-6999.191744 |
_version_ | 1782461372611690496 |
---|---|
author | Chen, Yu-Yang Liu, Qi Liu, Li Shu, Xiao-Rong Su, Zi-Zhuo Zhang, Hai-Feng Nie, Ru-Qiong Wang, Jing-Feng Xie, Shuang-Lun |
author_facet | Chen, Yu-Yang Liu, Qi Liu, Li Shu, Xiao-Rong Su, Zi-Zhuo Zhang, Hai-Feng Nie, Ru-Qiong Wang, Jing-Feng Xie, Shuang-Lun |
author_sort | Chen, Yu-Yang |
collection | PubMed |
description | BACKGROUND: Metabolic syndrome (MS) is a risk factor for stroke and thromboembolism event. Left atrial or LA appendage (LA/LAA) thrombus is a surrogate of potential stroke. The relationship between MS and atrial thrombus remains unclear. In this study, we sought to investigate the effect of MS on risk stratification of LA/LAA thrombus formation in patients with nonvalvular atrial fibrillation (NVAF). METHODS: This cross-sectional study enrolled 294 consecutive NVAF patients without prior anticoagulant and lipid-lowering therapies. LA/LAA thrombus was determined by transesophageal echocardiography. Risk assessment of LA/LAA thrombus was performed using the CHADS(2), CHA(2)DS(2)-VASc, MS, CHADS(2)-MS, and CHA(2)DS(2)-VASc-MS scores. Logistic regression analyses were performed to determine which factors were significantly related to LA/LAA thrombus. Odds ratio (OR) including 95% confidence interval was also calculated. The predictive powers of different scores for the risk of LA/LAA thrombus were represented by C-statistics and compared by receiver operating characteristic (ROC) analysis. RESULTS: LA/LAA thrombi were identified in 56 patients (19.0%). Logistic analysis showed that MS was the strongest risk factor for LA/LAA thrombus in NVAF patients (OR = 14.698, P < 0.001). ROC curve analyses revealed that the C-statistics of CHADS(2)-MS and CHA(2)DS(2)-VASc-MS was significantly higher than those of CHADS(2) and CHA(2)DS(2)-VASc scores (CHADS(2)-MS vs. CHADS(2), 0.807 vs. 0.726, P = 0.0019). Furthermore, MS was helpful for identifying individuals with a high risk of LA/LAA thrombus in the population with a low risk of stroke (CHADS(2) or CHA(2)DS(2)-VASc score = 0). CONCLUSIONS: MS is associated with LA/LAA thrombus risk in patients with NVAF. In addition to the CHADS(2) and CHA(2)DS(2)-VASc scores, the CHADS(2)-MS and CHA(2)DS(2)-VASc-MS scores provide additional information on stroke risk assessment. |
format | Online Article Text |
id | pubmed-5072249 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-50722492016-11-01 Effect of Metabolic Syndrome on Risk Stratification for Left Atrial or Left Atrial Appendage Thrombus Formation in Patients with Nonvalvular Atrial Fibrillation Chen, Yu-Yang Liu, Qi Liu, Li Shu, Xiao-Rong Su, Zi-Zhuo Zhang, Hai-Feng Nie, Ru-Qiong Wang, Jing-Feng Xie, Shuang-Lun Chin Med J (Engl) Original Article BACKGROUND: Metabolic syndrome (MS) is a risk factor for stroke and thromboembolism event. Left atrial or LA appendage (LA/LAA) thrombus is a surrogate of potential stroke. The relationship between MS and atrial thrombus remains unclear. In this study, we sought to investigate the effect of MS on risk stratification of LA/LAA thrombus formation in patients with nonvalvular atrial fibrillation (NVAF). METHODS: This cross-sectional study enrolled 294 consecutive NVAF patients without prior anticoagulant and lipid-lowering therapies. LA/LAA thrombus was determined by transesophageal echocardiography. Risk assessment of LA/LAA thrombus was performed using the CHADS(2), CHA(2)DS(2)-VASc, MS, CHADS(2)-MS, and CHA(2)DS(2)-VASc-MS scores. Logistic regression analyses were performed to determine which factors were significantly related to LA/LAA thrombus. Odds ratio (OR) including 95% confidence interval was also calculated. The predictive powers of different scores for the risk of LA/LAA thrombus were represented by C-statistics and compared by receiver operating characteristic (ROC) analysis. RESULTS: LA/LAA thrombi were identified in 56 patients (19.0%). Logistic analysis showed that MS was the strongest risk factor for LA/LAA thrombus in NVAF patients (OR = 14.698, P < 0.001). ROC curve analyses revealed that the C-statistics of CHADS(2)-MS and CHA(2)DS(2)-VASc-MS was significantly higher than those of CHADS(2) and CHA(2)DS(2)-VASc scores (CHADS(2)-MS vs. CHADS(2), 0.807 vs. 0.726, P = 0.0019). Furthermore, MS was helpful for identifying individuals with a high risk of LA/LAA thrombus in the population with a low risk of stroke (CHADS(2) or CHA(2)DS(2)-VASc score = 0). CONCLUSIONS: MS is associated with LA/LAA thrombus risk in patients with NVAF. In addition to the CHADS(2) and CHA(2)DS(2)-VASc scores, the CHADS(2)-MS and CHA(2)DS(2)-VASc-MS scores provide additional information on stroke risk assessment. Medknow Publications & Media Pvt Ltd 2016-10-20 /pmc/articles/PMC5072249/ /pubmed/27748329 http://dx.doi.org/10.4103/0366-6999.191744 Text en Copyright: © 2016 Chinese Medical Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Chen, Yu-Yang Liu, Qi Liu, Li Shu, Xiao-Rong Su, Zi-Zhuo Zhang, Hai-Feng Nie, Ru-Qiong Wang, Jing-Feng Xie, Shuang-Lun Effect of Metabolic Syndrome on Risk Stratification for Left Atrial or Left Atrial Appendage Thrombus Formation in Patients with Nonvalvular Atrial Fibrillation |
title | Effect of Metabolic Syndrome on Risk Stratification for Left Atrial or Left Atrial Appendage Thrombus Formation in Patients with Nonvalvular Atrial Fibrillation |
title_full | Effect of Metabolic Syndrome on Risk Stratification for Left Atrial or Left Atrial Appendage Thrombus Formation in Patients with Nonvalvular Atrial Fibrillation |
title_fullStr | Effect of Metabolic Syndrome on Risk Stratification for Left Atrial or Left Atrial Appendage Thrombus Formation in Patients with Nonvalvular Atrial Fibrillation |
title_full_unstemmed | Effect of Metabolic Syndrome on Risk Stratification for Left Atrial or Left Atrial Appendage Thrombus Formation in Patients with Nonvalvular Atrial Fibrillation |
title_short | Effect of Metabolic Syndrome on Risk Stratification for Left Atrial or Left Atrial Appendage Thrombus Formation in Patients with Nonvalvular Atrial Fibrillation |
title_sort | effect of metabolic syndrome on risk stratification for left atrial or left atrial appendage thrombus formation in patients with nonvalvular atrial fibrillation |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072249/ https://www.ncbi.nlm.nih.gov/pubmed/27748329 http://dx.doi.org/10.4103/0366-6999.191744 |
work_keys_str_mv | AT chenyuyang effectofmetabolicsyndromeonriskstratificationforleftatrialorleftatrialappendagethrombusformationinpatientswithnonvalvularatrialfibrillation AT liuqi effectofmetabolicsyndromeonriskstratificationforleftatrialorleftatrialappendagethrombusformationinpatientswithnonvalvularatrialfibrillation AT liuli effectofmetabolicsyndromeonriskstratificationforleftatrialorleftatrialappendagethrombusformationinpatientswithnonvalvularatrialfibrillation AT shuxiaorong effectofmetabolicsyndromeonriskstratificationforleftatrialorleftatrialappendagethrombusformationinpatientswithnonvalvularatrialfibrillation AT suzizhuo effectofmetabolicsyndromeonriskstratificationforleftatrialorleftatrialappendagethrombusformationinpatientswithnonvalvularatrialfibrillation AT zhanghaifeng effectofmetabolicsyndromeonriskstratificationforleftatrialorleftatrialappendagethrombusformationinpatientswithnonvalvularatrialfibrillation AT nieruqiong effectofmetabolicsyndromeonriskstratificationforleftatrialorleftatrialappendagethrombusformationinpatientswithnonvalvularatrialfibrillation AT wangjingfeng effectofmetabolicsyndromeonriskstratificationforleftatrialorleftatrialappendagethrombusformationinpatientswithnonvalvularatrialfibrillation AT xieshuanglun effectofmetabolicsyndromeonriskstratificationforleftatrialorleftatrialappendagethrombusformationinpatientswithnonvalvularatrialfibrillation |